adminMTE_04792022-07-05T13:27:04+00:00May 25th, 2022|Categories: AboutPharma|
La sfida di reclutare i pazienti adatti negli studi clinici ha da sempre rappresentato un ostacolo significativo ai programmi di sviluppo dei farmaci e dispositivi medici. La difficoltà di generare evidenze ritarda l'introduzione di nuovi interventi medici [...]
e.alvarado2022-07-05T08:49:15+00:00May 17th, 2022|Categories: Meditrial|Tags: Clinical Trial, Covid-19 vaccines, Drug Safety, Eudamed, PAES, PASS, POST-AUTHORIZATION STUDIES, SAFETY|
Over the course of two years of the pandemic, there have been heated debates about the safety and efficacy of the anti-Covid-19 vaccines. Even today, after more than 7 billion doses administered, issues continue to emerge about the available clinical [...]
adminMTE_04792022-07-05T13:35:47+00:00May 17th, 2022|Categories: AboutPharma|
Nel corso di due anni di pandemia, si sono susseguiti accesi dibattiti sulla sicurezza ed efficacia dei vaccini anti-Covid-19. Ancora oggi, dopo oltre 7 miliardi di dosi somministrate, continuano ad emergere problematiche sulle evidenze cliniche disponibili (Il Tempo). [...]
e.alvarado2022-07-05T13:37:51+00:00May 11th, 2022|Categories: Meditrial|Tags: Clinical Development, Clinical Trial, DIETARY SUPPLEMENTS, Food supplements, Functional foods, HOMEOSTASIS, NUTRACEUTICAL, Regulation 1924/2006|
Paola Antonini, Meditrial Scientific Director. Due to the pandemic and the information shared on social media, the increased attention of individuals to their own health and well-being has led to a considerable increase in the consumption of food supplements [...]
adminMTE_04792022-07-05T13:35:56+00:00May 11th, 2022|Categories: AboutPharma|
Paola Antonini, Direttore Scientifico Meditrial. Complici la pandemia e le informazioni condivise sui social media, l’accresciuta attenzione degli individui alla propria salute e benessere ha portato ad un notevole aumento dei consumi di integratori alimentari come [...]
e.alvarado2022-07-05T08:52:21+00:00May 4th, 2022|Categories: Meditrial|Tags: Clinical Development, Clinical Trial, DRUGS, Medical Devices, Pharmaceuticals|
Clinical development is a term traditionally used to define the entire process of bringing a new drug or medical device to market. It includes a pre-clinical phase to support human use and a clinical trial phase on patients, in compliance [...]
adminMTE_04792022-07-05T08:53:13+00:00May 4th, 2022|Categories: AboutPharma|
Nasce su AboutPharma Online, in Collaborazione con Meditrial, uno spazio per illustrare le nuove roadmap per lo sviluppo clinico e come prepararsi. Lo sviluppo clinico è un termine tradizionalmente utilizzato per definire l'intero processo di immissione sul [...]
k.janecek2023-03-29T13:55:52+00:00April 22nd, 2022|Categories: Compliance, Europe, Regulatory|Tags: Clinical Trial, Compliance, Pharma, pharmacovigilance, Regulatory|
In 2017, PRAC established a strategy for measuring the impact of pharmacovigilance activities, and EMA has published a second revision in April 2022. The second revision of the PRAC Impact Strategy integrates the achievements over a five-year period since its launch in [...]
Elena Trombettoni2024-02-29T14:33:14+00:00April 13th, 2022|Categories: Compliance, Europe, MDR|
The European Commission published a series of new UDI device related documents. UDI/Devices User Guide for Economic Operators EUDAMED UDI/Device data dictionary V2.7 UDI Device Business rules v2.7 UDI Device enumerations v2.7 MDR and IVDR introduce an EU device [...]
k.janecek2023-03-29T14:01:39+00:00April 13th, 2022|Categories: Compliance, Europe, MDR|Tags: Compliance, Europe, European Commission, European Union, IVD, IVDR, MDR, Medical Devices, MedTech|
The European Commission published a series of new UDI device related documents. UDI/Devices User Guide for Economic Operators EUDAMED UDI/Device data dictionary V2.7 UDI Device Business rules v2.7 UDI Device enumerations v2.7 MDR and IVDR introduce an EU device [...]
Become part of Meditrial! Subscribe to our newsletter.
Meditrial Europe - VAT CHE-115.033.718 © 2009 - 2025 | All Rights Reserved | Privacy | Terms of Use | Advertising Policy
